Ash Stevens Receives 2014 Lilly Global Supplier Award

Ash Stevens, a provider of global contract pharmaceutical drug substance development and API manufacturing services, received a 2014 Lilly Global Supplier Award.

“We are honored to receive this award and recognition from Eli Lilly and Company. Ash Stevens has a rich history that exceeds 50 years conducting innovative chemical research to develop and manufacture a wide variety of active pharmaceutical ingredients," said Dr. Stephen Munk, president and CEO.

To date, Ash Stevens has received twelve FDA manufacturing approvals for new APIs, including four fast-track manufacturing approvals for the active ingredients in the oncology drugs Velcade, Vidaza, Clolar, and Iclusig.

Source: Ash Stevens